Furthermore, higher serum sclerostin levels were independently associated with CVD in patients with T2D and significant correlations were found between serum sclerostin levels and cardiovascular risk factors such as age, diabetes duration, eGFR, LDL-c, calcium, diastolic blood pressure and periostin. Here, SOST is linked to diabetes mellitus.